Full Text
Clinical And Health-Economic Criteria for the Assessment of New Immune-Oncologic Drugs in Spain

Abstract

Authors

J López-Bastida J Oliva Moreno F Sánchez Martínez P González García

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×